Back
Credit Acceptance Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
69
CACC
Credit Acceptance
Last Price:
481.73
Seasonality Move:
7.2%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
45.66
Seasonality Move:
-24.57%
Buy
69
Credit Acceptance (CACC)
is a Buy
Is Credit Acceptance a Buy, Sell or Hold?
- The current Credit Acceptance [CACC] share price is $481.91. The Score for CACC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- CACC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $46.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CACC Stock Price Chart
What is Credit Acceptance's stock price today?
-
The Credit Acceptance share price today is $481.91
The current trend is moderately bullish and CACC is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $46.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
CACC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.78 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | 6591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (433.8 - 477.54) | Buy |
| Bollinger Bands (100): | (427.54 - 519.36) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.25 | Buy |
| Relative Strength Index (14 RSI): | 60.74 | Buy |
| Chaikin Money Flow: | 27470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.07 - 49.15) | Buy |
| Bollinger Bands (100): | (-4.58 - 36.14) | Buy |
CACC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 482.59 | Sell |
| 20-day SMA: | 460.61 | Buy |
| 50-day SMA: | 455.82 | Buy |
| 200-day SMA: | 498.38 | Sell |
| 8-day EMA: | 480.08 | Buy |
| 20-day EMA: | 467.66 | Buy |
| 50-day EMA: | 462.12 | Buy |
| 200-day EMA: | 482.29 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.02 | Buy |
| 20-day SMA: | 41.99 | Buy |
| 50-day SMA: | 30.41 | Buy |
| 200-day SMA: | 8.5 | Buy |
| 8-day EMA: | 42.03 | Buy |
| 20-day EMA: | 40.43 | Buy |
| 50-day EMA: | 32.24 | Buy |
| 200-day EMA: | 13.63 | Buy |
Credit Acceptance Earnings Growth & CACC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.66 per share, and an increase next year of $5.48 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Credit Acceptance Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||